Cargando…

Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines

Xylazine (1.1 mg/kg), butorphanol (0.02 mg/kg), guaifenesin 5% (20 mg/kg), and ketamine (2.2 mg/kg) combinations were able to induce short-term surgical anaesthesia for 23.33 ± 2.57 min in Spiti ponies with excellent to good muscle relaxation and analgesia. Urination and neighing was a constant feat...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Bhanu Partap Singh, Sharma, Sandeep Kumar, Sharma, Arvind, Kumar, Adarsh
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103860/
https://www.ncbi.nlm.nih.gov/pubmed/21647339
http://dx.doi.org/10.4061/2011/506831
_version_ 1782204560997089280
author Thakur, Bhanu Partap Singh
Sharma, Sandeep Kumar
Sharma, Arvind
Kumar, Adarsh
author_facet Thakur, Bhanu Partap Singh
Sharma, Sandeep Kumar
Sharma, Arvind
Kumar, Adarsh
author_sort Thakur, Bhanu Partap Singh
collection PubMed
description Xylazine (1.1 mg/kg), butorphanol (0.02 mg/kg), guaifenesin 5% (20 mg/kg), and ketamine (2.2 mg/kg) combinations were able to induce short-term surgical anaesthesia for 23.33 ± 2.57 min in Spiti ponies with excellent to good muscle relaxation and analgesia. Urination and neighing was a constant feature during recovery period. Biphasic P wave, biphasic T wave, and depressed PR segment were common electrocardiographic findings. Biochemical attributes were within physiological limits except a significant increase in ALT values during anaesthesia. The values returned to normal during recovery ruling out any renal or hepatic toxicity. Occasionally, negative T wave, notched P wave, and sinus block were noticed. It is recommended that the anaesthetic combinations xylazine-butorphanol-guaifenesin-ketamine can be safely used for short-term total intravenous anaesthesia (TIVA) in equines under field conditions.
format Text
id pubmed-3103860
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-31038602011-06-06 Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines Thakur, Bhanu Partap Singh Sharma, Sandeep Kumar Sharma, Arvind Kumar, Adarsh Vet Med Int Research Article Xylazine (1.1 mg/kg), butorphanol (0.02 mg/kg), guaifenesin 5% (20 mg/kg), and ketamine (2.2 mg/kg) combinations were able to induce short-term surgical anaesthesia for 23.33 ± 2.57 min in Spiti ponies with excellent to good muscle relaxation and analgesia. Urination and neighing was a constant feature during recovery period. Biphasic P wave, biphasic T wave, and depressed PR segment were common electrocardiographic findings. Biochemical attributes were within physiological limits except a significant increase in ALT values during anaesthesia. The values returned to normal during recovery ruling out any renal or hepatic toxicity. Occasionally, negative T wave, notched P wave, and sinus block were noticed. It is recommended that the anaesthetic combinations xylazine-butorphanol-guaifenesin-ketamine can be safely used for short-term total intravenous anaesthesia (TIVA) in equines under field conditions. SAGE-Hindawi Access to Research 2011-05-11 /pmc/articles/PMC3103860/ /pubmed/21647339 http://dx.doi.org/10.4061/2011/506831 Text en Copyright © 2011 Bhanu Partap Singh Thakur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Thakur, Bhanu Partap Singh
Sharma, Sandeep Kumar
Sharma, Arvind
Kumar, Adarsh
Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines
title Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines
title_full Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines
title_fullStr Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines
title_full_unstemmed Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines
title_short Clinical Evaluation of Xylazine-Butorphanol-Guaifenesin-Ketamine as Short-Term TIVA in Equines
title_sort clinical evaluation of xylazine-butorphanol-guaifenesin-ketamine as short-term tiva in equines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103860/
https://www.ncbi.nlm.nih.gov/pubmed/21647339
http://dx.doi.org/10.4061/2011/506831
work_keys_str_mv AT thakurbhanupartapsingh clinicalevaluationofxylazinebutorphanolguaifenesinketamineasshorttermtivainequines
AT sharmasandeepkumar clinicalevaluationofxylazinebutorphanolguaifenesinketamineasshorttermtivainequines
AT sharmaarvind clinicalevaluationofxylazinebutorphanolguaifenesinketamineasshorttermtivainequines
AT kumaradarsh clinicalevaluationofxylazinebutorphanolguaifenesinketamineasshorttermtivainequines